A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ART / antiretroviral treatment

[Related PubMed/MEDLINE]
Total Number of Papers: 1745
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ART  (>> Co-occurring Abbreviation)
Long Form:   antiretroviral treatment
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 "Closing the Gap": Provider Recommendations for Implementing Birth Point of Care HIV Testing. EID, POC
2019 "Even if she's really sick at home, she will pretend that everything is fine.": Delays in seeking care and treatment for advanced HIV disease in Kinshasa, Democratic Republic of Congo. DRC
2019 "Even if you're HIV-positive there's life after if you take your medication": experiences of people on long-term ART in South Africa: a short report. ---
2019 'Good health' as a barrier and facilitator to ART initiation: a qualitative study in the era of test-and-treat in Mozambique. ---
2019 A Phenomenological Account of HIV Disclosure Experiences of Children and Adolescents from Northern and Southern Ghana. UNAIDS
2019 A qualitative study on alcohol consumption and HIV treatment adherence among men living with HIV in Ugandan fishing communities. ---
2019 Adherence Connection for Counseling, Education, and Support: Research Protocol for a Proof-of-Concept Study. ACCESS, IRRID
2019 Adjustment to acute or early HIV-1 infection diagnosis to prompt linkage to care and ART initiation: qualitative insights from coastal Kenya. AEHI
2019 Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults. AR, OR, PR
10  2019 Attrition and treatment outcomes among adolescents and youths living with HIV in the Thai National AIDS Program. BIY, BIY1, BIY2, LTFU, NAP, PIY, PY
11  2019 Better Virological Outcomes amongst People Living with HIV Initiating Early Antiretroviral Treatment (CD4 counts ≥ 500 cells/L) in the HPTN 071 (PopART) Trial in South Africa. aHR, VF, VS
12  2019 Buffering Internalization of HIV Stigma: Implications for Treatment Adherence and Depression. PLWH
13  2019 Cardiovascular risk factors among ART-experienced people with HIV in South Africa. BP, CVD, DBP, IQR, PWH, RR, SBP
14  2019 Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection. CNS, CSF, NFL
15  2019 Clinico-pathological characteristics among South African women with breast cancer receiving anti-retroviral therapy for HIV. ---
16  2019 Comprehensive Profiling of HIV Antibody Evolution. ---
17  2019 Corrigendum to: Enumerating the population eligible for funded HIV pre-exposure prophylaxis (PrEP) in New Zealand. GBM, NZ, PHARMAC, PLWH, PrEP
18  2019 Designing an Individually Tailored Multilevel Intervention to Increase Engagement in HIV and Substance Use Treatment Among People Who Inject Drugs With HIV: HPTN 074. IDIs, MAT, PWID
19  2019 Determination of medication adherence and related factors among people living with HIV/AIDS in a Turkish university hospital PLWHA
20  2019 Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China. CRF, PDR
21  2019 Does the public antiretroviral treatment programme meet patients' needs? A study at four hospitals in eThekwini, KwaZulu-Natal, South Africa. ---
22  2019 Durability of first-line antiretroviral regimens in the era of integrase inhibitors: a cohort of HIV-positive individuals in Spain, 2014-2015. ABC, COBI, CoRIS, DTG, EFV, EVG, ORs, RPV, SHR, TC, VS
23  2019 Effect of hepatitis B virus (HBV) surface-gene variability on markers of replication during treated human immunodeficiency virus-HBV infection in Western Africa. HBV, HIV, MUPIQH, qHBsAg
24  2019 Effectiveness of Once/Day Dolutegravir Plus Boosted Darunavir as a Switch Strategy in Heavily Treated Patients with Human Immunodeficiency Virus. DTG, HIV, IQR, NNRTI, NRTI, PI, RAMs, VF
25  2019 Enumerating the population eligible for funded HIV pre-exposure prophylaxis (PrEP) in New Zealand. GBM, NZ, PHARMAC, PLWH, PrEP
26  2019 Evaluation of the ELIMIKA Pilot Project: Improving ART Adherence among HIV Positive Youth Using an eHealth Intervention in Mombasa, Kenya. ---
27  2019 Experience of Using an App in HIV Patients Older Than 60 Years: Pilot Program. ---
28  2019 Factors affecting the decision to initiate antiretroviral therapy in the era of treatment-as-prevention: synthesis of evidence from qualitative research in high-income settings. OECD, PLHIV
29  2019 First-line HIV treatment failures in non-B subtypes and recombinants: a cross-sectional analysis of multiple populations in Uganda. JCRC
30  2019 Heterogeneity in the costs of medical care among people living with HIV/AIDS in the United States. HIVRN, PWH, PWID
31  2019 How accurately do routinely reported HIV viral load suppression proportions reflect progress towards the 90-90-90 target in the population on antiretroviral treatment in Khayelitsha, South Africa? AOR, CI, UNAIDS, VL
32  2019 HTLV prevalence is no longer following the decreasing HIV prevalence - 20 years of retroviral surveillance in Guinea-Bissau, West Africa. ---
33  2019 Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study. HPV, HR-HPV, STIs, WLHIV
34  2019 Identification and characterization of HIV positive Ethiopian elite controllers in both Africa and Israel. ECs
35  2019 Identifying, linking, and treating people who inject drugs and were recently infected with HIV in the context of a network-based intervention. PWID, TRIP
36  2019 Impact of HIV-ART on the restoration of Th17 and Treg cells in blood and female genital mucosa. CMCs, FGT
37  2019 Impact of HIV/simian immunodeficiency virus infection and viral proteins on adipose tissue fibrosis and adipogenesis. ASCs, SCAT, VAT
38  2019 In Utero Efavirenz Exposure and Neurodevelopmental Outcomes in HIV-exposed Uninfected Children in Botswana. BSID-III, DMC, EFV, HEU, PSED
39  2019 Incidence, persistence, clearance and correlates of genital human papillomavirus infection and anogenital warts in a cohort of men living with HIV South Africa. AGW, MLHIV
40  2019 Incidence, Persistence, Clearance, and Correlates of Genital Human Papillomavirus Infection and Anogenital Warts in a Cohort of Men Living With Human Immunodeficiency Virus in South Africa. AGW, HPV, MLHIV
41  2019 Insulin Resistance in South African Youth Living with Perinatally Acquired HIV Receiving Antiretroviral Therapy. HOMA-IR, IQR, IR, YLPHIV
42  2019 Internal Working Models of Attachment Relationships and HIV Outcomes Among Women Living With HIV. ---
43  2019 Investigating the addition of oral HIV self-tests among populations with high testing coverage - Do they add value? Lessons from a study in Khayelitsha, South Africa. HIVST
44  2019 Knowledge and causal attributions for mental disorders in HIV-positive children and adolescents: results from rural and urban Uganda. ---
45  2019 Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines. CDC
46  2019 Liver damage in patients living with HIV on antiretroviral treatment with normal baseline liver function and without HBV/HCV infection: an 11-year retrospective cohort study in Guangxi, China. HBV, HCV, LEE, TBE
47  2019 Liver Enzyme Elevation in Pregnant Women Receiving Antiretroviral Therapy in the ANRS-French Perinatal Cohort. aHR, LEE
48  2019 Long-Term Effects of Psychological Interventions to Improve Adherence to Antiretroviral Treatment in HIV-Infected Persons: A Systematic Review and Meta-Analysis. AEIs, SMD
49  2019 Low adherence to Option B+ antiretroviral therapy among pregnant women and lactating mothers in eastern Tanzania. PMTCT
50  2019 Low body mass index and efavirenz use are independently associated with self-reported fatigue in HIV-infected patients. EFV
51  2019 Measuring adherence to antiretroviral therapy via hair concentrations in India. HAL, SJRI, SRA
52  2019 Mortality among pediatric patients on HIV treatment in sub-Saharan African countries: a systematic review and meta-analysis. CROI, IAS, SSA
53  2019 Multi-level Determinants of Clinic Attendance and Antiretroviral Treatment Adherence Among Fishermen Living with HIV/AIDS in Communities onLake Victoria, Uganda. ---
54  2019 Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters. HD, IM, mDC, pDC
55  2019 No Difference in Prevalence of Transmitted Drug Resistance between Injection Drug Users and Non-Injection Drug Users: A Cross-Sectional Study among Antiretroviral Treatment-Naive HIV Patients. IDUs, TDR
56  2019 Outcomes and implementation challenges of using daily treatment regimens with an innovative adherence support tool among HIV-infected tuberculosis patients in Karnataka, India: a mixed-methods study. aRR, TB
57  2019 Peripheral artery disease in HIV-infected older adults on antiretroviral treatment in Thailand. ABI, PAD
58  2019 Pharmacokinetics, Placental and Breastmilk Transfer of Antiretroviral Drugs in Pregnant and Lactating Women Living with HIV. ARV, PD, PK
59  2019 Pregnancy Outcomes in the Era of Universal Antiretroviral Treatment in Sub-Saharan Africa (POISE Study). LBW, PTB, SGA
60  2019 Presence, persistence and effects of pre-treatment HIV-1 drug resistance variants detected using next generation sequencing: A Retrospective longitudinal study from rural coastal Kenya. HIVDR, NGS, sVF
61  2019 Reaching 90-90-90: outcomes of a 15-year multi-country HIV workplace programme in sub-Saharan Africa. ---
62  2019 Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South Africa. AOR, CI, DoH, eEGFR, HPTN 071, IQR, PopART
63  2019 Retention and viral suppression of newly diagnosed and known HIV positive pregnant women on Option B+ in Western Kenya. ANC, KP, NP
64  2019 Risk Factors for Adverse Birth Outcomes in the PROMISE 1077BF/1077FF Trial. LBW, PI, PTD, VLBW, VPTD
65  2019 Schistosomiasis and HIV-1 viral load in HIV-infected outpatients with immunological failure in Tanzania: a case-control study. CAA, CD4
66  2019 Sex-specific neurogenic deficits and neurocognitive disorders in middle-aged HIV-1 Tg26 transgenic mice. HAND, WT
67  2019 Simplifying switch to second line ART: Predicted effect of defining failure of first-line efavirenz-based regimens in sub-Saharan Africa by a single viral load > 1000 copies/ml. VL, WHO
68  2019 Stigma against patients with HIV/AIDS in the rapid expansion of antiretroviral treatment in large drug injection-driven HIV epidemics of Vietnam. ---
69  2019 Stock-outs of antiretroviral and tuberculosis medicines in South Africa: A national cross-sectional survey. ---
70  2019 Suboptimal Immune Reconstitution among HIV-Infected Saudi Patients following Successful Antiretroviral Treatment. DT, ET, IQR
71  2019 Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women. TFV
72  2019 The association between ethnicity, stigma, beliefs about medicines and adherence in people living with HIV in a rural area in Indonesia. BMQ, CI, HIV, MARS, OR, PLHIV, WHO
73  2019 The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study. DALYs, PrEP, TWSW
74  2019 The Impacts of Residential Location on the Risk of HIV Virologic Failure Among ART Users in Durban, South Africa. SES, VF
75  2019 Timeliness of HIV Diagnosis and Antiretroviral Treatment Initiation in the Era of Universal Test and Treat. NYC
76  2019 Timing and Predictors of Initiation on Antiretroviral Therapy Among Newly-Diagnosed HIV-Infected Persons in South Africa. PLHIV, UTT
77  2019 Towards achieving the fast-track targets and ending the epidemic of HIV/AIDS in Ethiopia: Successes and challenges. CI, PLHIV
78  2019 Understanding why HIV-infected persons disengaged from pre-ART care in Freetown, Sierra Leone: a qualitative study. LTFU
79  2019 Use of Antiretroviral Drug Testing to Assess the Accuracy of Self-reported Data from HIV-Infected People Who Inject Drugs. ARV
80  2019 VDR rs2228570 Polymorphism Is Related to Non-Progression to AIDS in Antiretroviral Therapy Naive HIV-Infected Patients. AOR, LTNPs, MPs, RPs, SNPs, VDR
81  2019 What do the implementation outcome variables tell us about the scaling-up of the antiretroviral treatment adherence clubs in South Africa? A document review. ACs
82  2019 Work and home productivity of people living with HIV in Zambia and South Africa. CI
83  2018 "My future is bright…I won't die with the cause of AIDS": ten-year patient ART outcomes and experiences in South Africa. CI, LTF
84  2018 "[Drinking is] Like a Rule That You Can't Break": Perceived Barriers and Facilitators to Reduce Alcohol Use and Improve Antiretroviral Treatment Adherence among People Living with HIV and Alcohol Use Disorder in Vietnam. AUDs, PLHIV
85  2018 'Yummy or crummy?' The multisensory components of medicines-taking among HIV-positive youth. ---
86  2018 90-90-90 HIV targets: implications for HIV-associated tuberculosis. IPT, PLHIV, TB
87  2018 Acceptability of Mobile Phone-Based Nurse-Delivered Counseling Intervention to Improve HIV Treatment Adherence and Self-Care Behaviors Among HIV-Positive Women in India. ---
88  2018 Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya. AOR, CI, PI, VL
89  2018 Adult neurogenic deficits in HIV-1 Tg26 transgenic mice. HAND, NSCs, SGZ
90  2018 Alcohol Use and HIV Disease Progression in an Antiretroviral Naive Cohort. ---
91  2018 An urgent need for HIV testing among men who have sex with men and transgender women in Bamako, Mali: Low awareness of HIV infection and viral suppression among those living with HIV. MSM, TGW
92  2018 Antiretroviral treatment Long-Term (ALT) cohort: a prospective cohort of 10 years of ART-experienced patients in Uganda. ALT, IDI
93  2018 Application of MT-4 neoplasm cell line for the immunomodulating activity study of patients plasma with HIV-infection. ---
94  2018 Assessing the utility of the tipping point ratio to monitor HIV treatment programmes in the era of universal access to ART. TPR
95  2018 Assessment of Transmitted HIV-1 Drug Resistance Mutations Using Ultra- Deep Pyrosequencing in a Turkish Cohort. HIV, PDRMs, TDRMs, UDPS
96  2018 Association of raltegravir use with long-term health outcomes in HIV-infected patients: an observational post-licensure safety study in a large integrated healthcare system. HR
97  2018 Associations between sleep parameters, non-communicable diseases, HIV status and medications in older, rural South Africans. NCDs
98  2018 Attrition when providing antiretroviral treatment at CD4 counts >500cells/muL at three government clinics included in the HPTN 071 (PopART) trial in South Africa. DoH
99  2018 Availability of HIV services along the continuum of HIV testing, care and treatment in Ghana. EID, HTS, OI, PMTCT
100  2018 Barriers and facilitators to the uptake of Test and Treat in Mozambique: A qualitative study on patient and provider perceptions. FGDs, IDIs